Cervical infection epidemiology of human papillomavirus in Ushuaia, Argentina;Epidemiología de la infección cervical por virus Papiloma humano en Ushuaia, Argentina

Revista Argentina de Microbiologia

Volumn 38, Issue 1, 2006, Pages 19-24

  Sijvarger, C C ^a   Gonzalez J V ^c   Prieto, A ^b   Messmer, A G ^b   Mallimaci, M C ^a   Alonio, V L ^c   Teyssie A R ^c   Picconi, M A ^c  

^a Hospital Regional Ushuaia Gobernador Ernesto Campos   (Argentina)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

Author keywords

Cancer of the cervix; Cervical infection; Human papillomavirus; Ushuaia; Viral typification

Indexed keywords

ADOLESCENT; ADULT; ARGENTINA; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HYBRIDIZATION; INCIDENCE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; UTERINE CERVICITIS; UTERINE CERVIX CANCER; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS TYPING; WART VIRUS;

ADOLESCENT; ADULT; ARGENTINA; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA PROBES, HPV; FEMALE; HUMANS; IMMUNOBLOTTING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PRECANCEROUS CONDITIONS; PREGNANCY; PREVALENCE; URBAN POPULATION; UTERINE CERVICAL NEOPLASMS; UTERINE CERVICITIS; VAGINAL SMEARS;

EID: 33745137102     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Abba MC, Gómez MA, Golijow CD. Distribución de los genotipos del virus papiloma humano en infecciones cervicales en mujeres de La Plata, Argentina. Rev Argent Microbiol 2003; 35: 74-9.
2. Amestoy GM, Matos E, Loria D, Herrera L, Prince MA, Moreno J, et al. Prevalencia de la infección por papiloma virus humano del cuello uterino en la población del departamento de Concordia, Entre Ríos. Colposcopía 2000; 11: 73-9.
3. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, et al. Identification and assessment of known and novel human papillomavirus by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994; 170: 1077-85.
4. Bosch FX, Loríncz A, Muñoz N, Meijer CJLM, Shah K. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-65.
5. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995; 87: 796-802.
6. Cuschieri KS, Cubie HA, Whitley MW, Seagar AL, Arends MJ, Moore C, et al. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 2004; 57: 68-72.
7. Cuzik J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D, et al. Management of women who test positive for high-risk types of human papilloma virus: the HART study. Lancet 2003; 362: 1871-6.
8. Fife KH, Cramer HM, Schroeder JM, Brown DR. Detection of multiple papillomavirus types in the lower genital tract correlates with cervical dysplasia. J Med Virol 2001; 64: 550-9.
9. Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Desy M, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999; 180: 1415-23.
10. Instituto Nacional de Estadisticas y Censos (INDEC). Censo Nacional de Población, Hogares y Vivienda 2001, Argentina. Disponible en: www.indec.mecon.gov.ar. Acceso el 7 de febrero de 2005.
11. Instituto Nacional de Estadísticas y Censos (INDEC). Censo Nacional de Población, Hogares y Vivienda 1991, Argentina. Disponible en: www.indec.mecon.gov.ar. Acceso el 7 de febrero de 2005.
12. IARC Working Group. Human Papillomaviruses. Monographs on the evaluation of carcinogenic risks to humans. International Agency for Research on Cancer (IARC)- World Health Organization (WHO); Vol. 64, 1995.
13. Jacobs MV, de Roda Husman AM, Van den Brule AJ, Snijders PJ, Meijer CJ, Walboomers JM. Group-specific differentiations between high, and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotides probes. J Clin Microbiol 1995; 33: 901-5.
14. Jacobs MV, Walboomers JMM, Snijders PJF, Voorhorst FJ, Verheuen RHM, Fransen-Daalmeijer N, et al. Distribution of 37 mucosotropic HPV types in women with citologically normal cervical smears: the age-related patterns for high-risk and low- risk types. Int J Cancer 2000; 87: 221-7.
15. Lazcano-Ponce E, Herrero R, Muñoz N, Cruz A, Shah KV, Alonso P, et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001; 91: 412-20.
16. Liaw KL, Glass AG, Manos MM, Greer CE, Scott DR, Sherman M, et al. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst 1999; 91: 954-60.
17. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. The use of polymerase chain reaction amplification of DNA with a thermostable DNA polymerase. Cancer Cell 1989; 7: 209-14.
18. Matos EL, Loria DI, Zengarini N, Fernández MM, Guebel CG, Marconi E, et al. Jurisdicciones. Tasas ajustadas de mortalidad para los principales sitios tumorales y pirámide de población. En: Matos EL, Loria DI, editors. Atlas de Mortalidad por cáncer en Argentina 1997-2001. Ministerio de Salud de la Nación, Argentina. Buenos Aires, 2003, p. 139-43.
19. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27.
20. Parkin D, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80: 827-41.
21. Picconi MA, Gronda J, Alonio LV, Villa LL, Sichero L, Miranda S, et al. Virus papiloma humano en mujeres quechuas jujeñas con alta frecuencia de cancer de cuello uterino. Medicina (Buenos Aires) 2002; 62: 209-20.
22. Rolón PA, Smith JS, Muñoz N, Klug SJ, Herrero R, Bosch X, et al. Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer 2000; 85: 486-91.
23. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487-91.
24. Schiller JT, Lowy DR. Papillomavirus-like particle based vaccines: cervical cancer and beyond. Expert Opin Biol Ther 2001; 1: 571-81.
25. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287: 2114-9.
26. Teyssié A. Papilomavirus. En: Carballal G, Oubiña JR, editors. Virología Médica. Argentina, El Ateneo, 1998, p. 349-63.
27. Tonon SA, Picconi MA, Zinovich JB, Nardari W, Mampaey M, Galuppo JA, et al. Prevalencia de la infección cervical por virus papiloma humano (HPV) en población caucásica y guaraní, residente en la provincia de Misiones, Argentina. Rev Argent Microbiol 2003; 35: 205-13.
28. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-9.
29. World Health Organization (WHO) - International Agency for Research on Cancer (IARC). The current status of development of prophylactic vaccines against human papillomavirus infection; Reporte de la tercer reunión técnica, 1999. Ginebra, Suiza.
30. Zur Hausen H. Papillomavirus infections, a major cause of human cancer. Biochem Biophys 1996; Acta 1288: 55-78.